Steward Partners Investment Advisory’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.7K | Buy |
2,266
+16
| +0.7% | +$443 | ﹤0.01% | 2360 |
|
|
2025
Q1 | $50K | Hold |
2,250
| – | – | ﹤0.01% | 2386 |
|
|
2024
Q4 | $44.5K | Hold |
2,250
| – | – | ﹤0.01% | 2400 |
|
|
2024
Q3 | $56.2K | Hold |
2,250
| – | – | ﹤0.01% | 2173 |
|
|
2024
Q2 | $42K | Hold |
2,250
| – | – | ﹤0.01% | 2187 |
|
|
2024
Q1 | $44.4K | Hold |
2,250
| – | – | ﹤0.01% | 2176 |
|
|
2023
Q4 | $39.5K | Hold |
2,250
| – | – | ﹤0.01% | 2096 |
|
|
2023
Q3 | $39.1K | Buy |
2,250
+250
| +13% | +$4.34K | ﹤0.01% | 2022 |
|
|
2023
Q2 | $28.2K | Hold |
2,000
| – | – | ﹤0.01% | 2116 |
|
|
2023
Q1 | $21.5K | Hold |
2,000
| – | – | ﹤0.01% | 2222 |
|
|
2022
Q4 | $30K | Hold |
2,000
| – | – | ﹤0.01% | 2046 |
|
|
2022
Q3 | $26K | Hold |
2,000
| – | – | ﹤0.01% | 2092 |
|
|
2022
Q2 | $19K | Hold |
2,000
| – | – | ﹤0.01% | 2246 |
|
|
2022
Q1 | $20K | Hold |
2,000
| – | – | ﹤0.01% | 2363 |
|
|
2021
Q4 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 2246 |
|
|
2021
Q3 | $23K | Hold |
2,000
| – | – | ﹤0.01% | 2263 |
|
|
2021
Q2 | $28K | Hold |
2,000
| – | – | ﹤0.01% | 4382 |
|
|
2021
Q1 | $37K | Buy |
2,000
+1,000
| +100% | +$18.5K | ﹤0.01% | 2146 |
|
|
2020
Q4 | $18K | Buy |
1,000
+500
| +100% | +$9K | ﹤0.01% | 2097 |
|
|
2020
Q3 | $8K | Buy |
+500
| New | +$8K | ﹤0.01% | 2219 |
|